#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Radiolabelled peptides in the diagnosis and therapy of tumours


Authors: J. Cihlo;  M. Lázníček
Authors‘ workplace: Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, katedra farmakologie a toxikologie
Published in: Čes. slov. Farm., 2008; 57, 70-77
Category: Review Articles

Overview

In the last two decades, radiolabelled receptor-specific peptides have profiled themselves as excellent tools that have expressively increased the diagnostic and therapeutical possibilities of tumours predominantly of neuroendocrine origin. The aim of this review paper is to transparently inform the Czech scientific fraternity about the significance and limitations of the use of this group of radiopharmaceuticals in clinical practice.

Key words:
radiopharmaceuticals – diagnosis – therapy – cancers – receptor-specific peptides


Sources

1. Reubi, J. C.: Endocr. Rev., 2003; 24, 389–427.

2. de Herder, W. W., Lamberts, S. W.: Curr. Opin. Oncol., 2002; 14, 53–57.

3. Lamberts, S. W., de Herder, W. W., Hofland, L. J.: Trends Endocrinol. Metab., 2002; 13, 451–457.

4. Behr, T. M., Behe, M., Becker, W.: Q. J. Nucl. Med., 1999; 43, 268–280.

5. de Visser, M., Janssen, P. J., Srinivasan, A. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 1134–1139.

6. Koikov, L. N., Ebetino, F. H., Solinsky, M. G. et al.: Bioorg. Med. Chem. Lett., 2003; 13, 2647–2650.

7. Reubi, J. C., Waser, B., Schaer, J. C., Laissue, J. A.: Eur. J. Nucl. Med., 2001; 28, 836–846.

8. Weiner, R. E.,Thakur, M. L.: BioDrugs, 2005; 19, 145–163.

9. Breeman, W. A., Kwekkeboom, D. J., de Blois, E. et al.: Anticancer Agents Med. Chem., 2007; 7, 345–357.

10. Patel, Y. C., Greenwood, M. T., Panetta, R. et al.: Life Sci., 1995; 57, 1249–1265.

11. Scherubl, H., Hescheler, J.,Riecken, E. O.: Horm. Metab. Res. Suppl., 1993; 27, 1–4.

12. Reubi, J. C.: Neuroendocrinology, 2004; 80 (Suppl. 1), 51–56.

13. Blok, D., Feitsma, R. I., Vermeij, P., Pauwels, E. J.: Eur. J. Nucl. Med., 1999; 26, 1511–1519.

14. Hejna, M., Schmidinger, M., Raderer, M.: Ann. Oncol., 2002; 13, 653–668.

15. Gotthardt, M., Boermann, O. C., Behr, T. M. et al.: Curr. Pharm. Des., 2004; 10, 2951–2963.

16. Breeman, W. A., de Jong, M., Kwekkeboom, D. J. et al.: Eur. J. Nucl. Med., 2001; 28, 1421–1429.

17. Wild, D., Schmitt, J. S., Ginj, M. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 1338–1347.

18. Virgolini, I., Traub, T., Novotny, C. et al.: Curr. Pharm. Des., 2002; 8, 1781–1807.

19. Decristoforo, C., Maina, T., Nock, B. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 1211–1219.

20. Kopecky, M., Trejtnar, F., Laznicek, M. et al.: Nucl. Med. Commun., 2005; 26, 549–554.

21. Maina, T., Nock, B., Nikolopoulou, A. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2002; 29, 742–753.

22. Maina, T., Nock, B. A., Cordopatis, P. et al.: Eur. J. Nucl. Med. Mo. Imaging, 2006; 33, 831–840.

23. Decristoforo, C., Mather, S. J., Cholewinski, W. et al.: Eur. J. Nucl. Med., 2000; 27, 1318–1325.

24. Decristoforo, C., Melendez-Alafort, L., Sosabowski, J. K., Mather, S. J.: J. Nucl. Med., 2000; 41, 1114–1119.

25. Cremonesi, M., Ferrari, M., Bodei, L. et al.: J. Nucl. Med., 2006; 47, 1467–1475.

26. de Jong, M., Breeman, W. A., Bernard, B. F. et al.: Int. J. Cancer, 2001; 92, 628–633.

27. Lewis, J. S., Wang, M., Laforest, R. et al.: Int. J. Cancer, 2001; 94, 873–877.

28. Bugaj, J. E., Erion, J. L., Johnson, M. A. et al.: Nucl. Med. Biol., 2001; 28, 327–334.

29. Cyr, J. E., Pearson, D. A., Wilson, D. M. et al.: J. Med. Chem., 2007; 50, 1354–1364.

30. Lewis, J. S., Lewis, M. R., Cutler, P. D. et al.: Clin. Cancer Res., 1999; 5, 3608–3616.

31. Lewis, J. S., Srinivasan, A., Schmidt, M. A., Anderson, C. J.: Nucl. Med. Biol., 1999; 26, 267–273.

32. Blower, P.: Dalton Trans, 2006; 1705–1711.

33. Lister-James, J., Moyer, B. R.,Dean, R. T.: Q. J. Nucl. Med., 1997; 41, 111–118.

34. Kaltsas, G. A., Papadogias, D., Makras, P., Grossman, A. B.: Endocr. Relat. Cancer, 2005; 12, 683–699.

35. Caplin, M. E., Buscombe, J. R., Hilson, A. J. et al.: Lancet, 1998; 352, 799–805.

36. Gibril, F., Reynolds, J. C., Doppman, J. L. et al.: Ann. Intern. Med., 1996; 125, 26–34.

37. Cremonesi, M., Ferrari, M., Bodei, L. et al.: Q. J. Nucl. Med. Mol. Imaging, 2006; 50, 288–295.

38. Forrer, F., Valkema, R., Kwekkeboom, D. J. et al.: Best. Pract. Res. Clin. Endocrinol. Metab, 2007; 21, 111–129.

39. Teunissen, J. J., Kwekkeboom, D. J., de Jong, M. et al.: Best. Pract. Res. Clin. Gastroenterol., 2005; 19, 595–616.

40. Capello, A., Krenning, E. P., Breeman, W. A. et al.: J. Nucl. Med., 2003; 44, 98–104.

41. de Jong, M., Bakker, W. H., Krenning, E. P. et al.: Eur. J. Nucl. Med., 1997; 24, 368–371.

42. Krenning, E. P., de Jong, M., Kooij, P. P. et al.: Ann. Oncol., 1999; 10 (Suppl. 2), S23–S29.

43. Anderson, C. J., Dehdashti, F., Cutler, P. D. et al.: J. Nucl. Med., 2001; 42, 213–221.

44. Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P. et al.: Eur. J. Nucl. Med., 2001; 28, 1319–1325.

45. Deutsch, E., Libson, K., Vanderheyden, J. L. et al.: Int. J. Rad. Appl. Instrum. B, 1986; 13, 465–477.

46. Cremonesi, M., Ferrari, M., Zoboli, S. et al.: Eur. J. Nucl. Med., 1999; 26, 877–886.

47. Pauwels, S., Barone, R., Walrand, S. et al.: J. Nucl. Med., 2005; 46 (Suppl. 1), 92S–98S.

48. Engstrom, P. F., Lavin, P. T., Moertel, C. G. et al.: J. Clin. Oncol., 1984; 2, 1255–1259.

49. Bodei, L., Cremonesi, M., Zoboli, S. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 207–216.

50. Barone, R., Borson-Chazot, F., Valkema, R. et al.: J. Nucl. Med., 2005; 46 (Suppl. 1), 99S–106S.

51. Rolleman, E. J., Valkema, R., de Jong, M. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 9–15.

52. van Eerd, J. E., Vegt, E., Wetzels, J. F. et al.: J. Nucl. Med., 2006; 47, 528–533.

53. Vegt, E., Wetzels, J. F., Russel, F. G. et al.: J. Nucl. Med., 2006; 47, 432–436.

54. Behe, M., Kluge, G., Becker, W. et al.: J. Nucl. Med., 2005; 46, 1012–1015.

55. Gotthardt, M., van Eerd-Vismale, J., Oyen, W. J. et al.: J. Nucl. Med., 2007; 48, 596–601.

56. Barone, R., Van Der Smissen, P., Devuyst, O. et al.: Kidney Int., 2005; 67, 969–976.

57. de Jong, M., Barone, R., Krenning, E. et al.: J. Nucl. Med., 2005; 46, 1696–1700.

58. Melis, M., Krenning, E. P., Bernard, B. F. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2005; 32, 1136–1143.

59. Christensen, E. I., Nielsen, R.: Rev. Physiol. Biochem. Pharmacol., 2007; 158, 1–22.

60. Christensen, E. I.,Verroust, P. J.: Pediatr. Nephrol., 2002; 17, 993–999.

61. Verroust, P. J.,Christensen, E. I.: Nephrol. Dial. Transplant., 2002; 17, 1867–1871.

62. Moestrup, S. K., Cui, S., Vorum, H. et al.: J. Clin. Invest., 1995; 96, 1404–1413.

63. Rolleman, E. J., Forrer, F., Bernard, B. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2007; 34, 763–771.

64. Bodei, L., Cremonesi, M., Grana, C. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2004; 31, 1038–1046.

65. de Jong, M., Valkema, R., Jamar, F. et al.: Semin. Nucl. Med., 2002; 32, 133–140.

66. Reubi, J. C.,Waser, B.: Eur. J. Nucl. Med. Mol. Imaging, 2003; 30, 781–793.

67. Reubi, C., Gugger, M., Waser, B.: Eur. J. Nucl. Med. Mol. Imaging, 2002; 29, 855–862.

68. van Hagen, P. M., Breeman, W. A., Bernard, H. F. et al.: Int. J. Cancer, 2000; 90, 186–198.

69. Schumacher, T., Hofer, S., Eichhorn, K. et al.: Eur. J. Nucl. Med. Mol. Imaging, 2002; 29, 486–493.

Labels
Pharmacy Clinical pharmacology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#